MORA THERAPY-BIORESONANCE IN IN THE TREATMENT OF SMOKING ADDICTION

Assoc. Dr. Kamile MARAKOĞLU

11th NATIONAL FAMILY MEDICINE CONGRESS-ANTALYA 2012
Assoc. Dr. Kamile MARAKOĞLU*
Dr. Nisa Çetin KARGIN*
Nurse Sema KAYSILI*
Dr. Handan DAL *

*Selçuk University Selçuklu Faculty of Medicine, Department of Family Medicine, KONYA, Türkiye.
INTRODUCTION AND PURPOSE
Smoking addiction ranks first among preventable causes of death worldwide. In the 2008 clinical practice guideline by the US Department of Health, nicotine replacement therapies (nicotine gum, nicotine patch, nicotine inhaler, nicotine lozenge), Bupropion, Varenicline, Nortriptyline, and Clonidine were listed as effective treatments for smoking cessation. Among these, nicotine replacement therapies, Bupropion, and Varenicline were recommended as the first-choice medications (1).
For the last 4 years, smoking cessation treatment with Mora Therapy has been implemented in our country. The Mora-Bioresonance method, first used by the German doctor Franz Morell in the 1970s, is a complementary medicine method that aims to intervene in the body through weak electromagnetic frequencies specific to substances, and it is performed with the help of medical devices produced for this purpose (2-4). Although this treatment has been shown to be applicable for various indications, its use in addiction treatment has become particularly widespread in recent years (3,4). In 2008, a double-blind placebo-controlled study conducted by Pihtili and colleagues at the Chest Diseases Department of Çapa Medical Faculty demonstrated the efficacy of this method over a one-year follow-up period with 200 patients (5). A study by Dr. Işık, conducted between 2007-2011 with 4733 participants, found the success rates of smoking cessation with Mora Therapy to be 62.1% at one month and 48.2% at three months (6). Another study by Karadağ and colleagues, involving 1562 patients who sought smoking cessation treatment between 2009-2011, reported a 69.13% success rate at one month, with 85.66% of patients reached by phone for follow-up (7)
Our study is a prospective study and aims to investigate the one- and three-month success rates of patients receiving Mora Therapy as a smoking cessation treatment.

MATERIAL and METHOD
Between September 27, 2010, and February 1, 2012, 375 patients who wanted to receive Mora Therapy for smoking cessation applied to the Smoking Cessation Clinic of Selçuk University Selçuklu Faculty of Medicine. These patients received 3 therapy sessions in a month to quit smoking with Mora Therapy. The success status of the patients at the 1st and 3rd months was recorded by inquiring through face-to-face interviews and telephone checks. Patients who could not be reached during follow-up visits were not included in the study. 375 patients were interviewed on the 3rd day after therapy. 359 patients completed the 1st month and 309 patients completed the 3rd month. The success status of the patients was recorded using the SPSS 16.0 package program. Data were analyzed using frequency, percentage, mean and standard deviation, median, Chi-square test, and Pearson Correlation analysis.
The Mora Therapy device is classified as a Class 3 medical device by the Turkish Ministry of Health, and its use in smoking addiction is at the discretion of the relevant clinician. It is certified in Germany as an electroacupuncture and electrostimulation device.
RESULTS
Of the admitted patients (n=375), 76.0% were male (n=285) and 24.0% (n=90) were female. The average age was 41.35±10.96 (median=41.00, min=20, max=74). The overall success rate of smoking cessation on the third day was 90.4% (n = 339/375). The success rate of quitting smoking in the first month was 66.3% (238/359), and the success rate in 3 months was 46.6% (144/309). o statistically significant difference was found between men and women in smoking cessation success rates at one month (64.8%-66.8%, p=0.827) and three months (42.3%-48.1%, p=0.454). A positive relationship was found between age and 1st month smoking cessation and 3rd month smoking cessation (r=0.227 p=0.000; r=0.173 p=0.002, respectively). (Table 1)
Table 1-Correlation Between Age and Smoking Quit Rates

 

 

DISCUSSION AND CONCLUSION
According to the results we obtained from our study, the success rates of smoking cessation at one and three months for patients who received Mora Therapy are generally similar to the results of other Mora Therapy studies conducted in our country, and are relatively higher compared to recent studies on drug use abroad (Bupropion: 7-12 week success rate 20%-39.0%, Varenicline: 12 week success rate 29.7%-40.0) (8-10). According to a similar study we recently conducted in our smoking cessation clinic (1st month success rate in those using Bupropion, 50.6%, 3 month success rate 38.1% - 1st month success rate in those using Varenicline, 63.9%, 3 month success rate 47.8%), the results were found to be similar. This suggests that Mora Therapy, one of the newly used methods in the treatment of smoking addiction, is effective in smoking cessation treatment. Mora Therapy is an effective, safe and side-effect-free method to quit smoking.

REFERENCES

1- Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD:U.S. Depatment of Health and Human Services. Publich Health Service. May
2008.
2- Morell F: MORA-Therapie – patienteneigene und Farblicht-schwingungen. Heidelberg, Haug 1987.
3- Herrmann E: Das MORA-Praxisbuch – Therapie mit körpereigenen Schwingungen. Haug, Heidelberg 1998.
4- Nienhaus J, Galle M: Placebokontrollierte Studie zur Wirkung einer standardisierten MORA Bioresonanztherapie auf funktionelle Magen-5-Darm-Beschwerden. Forschende
Komplementärmedizin 2006 13:28-34.
5- Pihtili A, Cuhhadraroglu C, Kilicaslan Z, Issever H, Erkan F: The effectiveness of bioresonance method in quitting smoking. Clinical report 2009, Department of Medicine, University Istanbul, Turkey (in preparation for
publication).
6- Işık E. Evidence for efficacy and effectiveness of the MORA Bioresonance method in smoking cessation. Poster presented during 4 European Congress for Integrative Medicine - Berlin, October 07 - 08 in 2011.
7-Karadağ M, Karadağ S, Ediz B ve Işık E. Nikotin Bağımlılığının Sigara Bırakmadaki Etkisi. Yeni Tıp Dergisi 2011;29(1):27-31.
8-Schmelzle J, Rosser WW, Birtwhistle R. Update on pharmacologic and nonpharmacologic therapies for smoking cessation. Can Fam Physician. 2008 Jul;54(7):994-9. Review.
9-Nides M,Glover ED,Reus IV.Varenicline versus bupropion SR or placebo for smoking cessation:A pooled analysis.Am J Health Behov.2008;32(6):664-675
10-Gonzales D,Jorenby DE,Brandon TH.İmmediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline,bupropion SR or placebo.Addiction.105.2002-2013.